Antimicrobial peptide LL-37 contributes to thrombotic complications in patients with COVID-19
According to research published in Cellular and Molecular Life Sciences, an antimicrobial peptide of catelicidin, LL-37, appears to be elevated during SARS-CoV-2 infection and may contribute to hypercoagulation in patients with COVID-19. The researchers evaluated the role of LL-37 in patients with confirmed COVID-19 at Chongqing Public Health Medical Center and the Department of Infectious …